Body dysmorphia statistics: how common BDD really is, what it looks like in men, and why it goes unasked

You are staring at a mirror, then a front-camera photo, then the mirror again. The question is whether the time and distress this takes have crossed into something with a name.

The headline answer is about 2% of adults: a systematic review estimated 1.9% in community samples, while a US nationwide survey found 2.2% of men and 2.5% of women. Body dysmorphic disorder (BDD) is not rare, and it is not mainly a women’s problem. It is mostly not rare — unasked.

This page separates diagnoses from screening results, community samples from specialist clinics, and appearance concerns from the disorder itself.

Key numbers

• 1.9% of community adults met pooled BDD prevalence estimates in a 2016 systematic review. Source
• 2.2% of US men versus 2.5% of US women were estimated to have BDD in a nationwide adult survey. Source
• 20.1% in rhinoplasty settings, about 10.6 times the community adult rate in the same review. Source
• 0 of 500 psychiatric outpatients were diagnosed by routine interview, versus 3.2% with a structured interview. Source
• BDD severity improved after only 2.3% of cosmetic treatments in one clinical study. Source
• 1.3% of Spanish university men met interview-confirmed muscle dysmorphia criteria. Source

Table of contents

• How common is body dysmorphic disorder?
• Do men get body dysmorphia as often as women?
• What do men with BDD focus on?
• How common is muscle dysmorphia among men who lift?
• Why is BDD so common in cosmetic and dermatology clinics, and does cosmetic surgery help?
• How often is body dysmorphia missed?
• How serious is it, and does it get better with treatment?
• How to cite this page
• The bottom line
• Sources

How common is body dysmorphic disorder?

BDD affects roughly 2% of adults in broad estimates, but there is no single definitive community number. A 2016 review estimated 1.9% of adults, 2.2% of adolescents, and 3.3% of students; a 2024 overview likewise describes about 2% of adults and underdiagnosis. (Veale et al.; Rück et al.)

The catch is method: questionnaires and structured interviews produce different estimates. A structured-interview meta-analysis found 20.0% in cosmetic and dermatology settings, 7.4% in mental health, and 6.7% elsewhere; no large population studies using diagnostic interviews were available as of 2023. (McGrath et al.)

German surveys reported 1.7% and 1.8%; another sample found 2.9% under DSM-5 and 3.2% under DSM-IV. These are landmarks, not resolution.

BDD means persistent preoccupation with perceived flaws causing distress or disruption, not ordinary dislike of a photo or a style goal. If worries take up hours or stop activities, seek professional help; BDD is treatable. (NICE)

Caveat: 1.9% pools heterogeneous studies; it is an orientation point, not a census.

Do men get body dysmorphia as often as women?

In adults, the available evidence does not support a major gender gap. A US survey estimated 2.2% of men and 2.5% of women, a non-meaningful difference; a 2024 primer finds no major adult disparity. (Koran et al.; Rück et al.)

Swedish twin cohorts found symptoms in 1–2% overall, with 1.3–3.3% of females and 0.2–0.6% of males reaching a screening cut-off; it is not a diagnosis and may under-detect muscularity concerns. (Enander et al.)

The widely shared “60% women, 40% men” split has no clear population source; the national adult figures above are 2.5% and 2.2%. Men’s concerns also tend to show up as body build, genitals or weightlifting, which checklists built around skin or weight can miss.

The useful reframe is not rare — unasked. See the male body-image statistics guide.

Caveat: the US survey had 49 cases, so it cannot establish a fine-grained sex difference.

What do men with BDD focus on?

Men with BDD often focus on body build, genitals, and muscularity-related behaviors, while skin, hair, and facial features remain common overall. In 200 people with BDD, concerns included skin at 80.0%, hair at 57.5%, nose at 39.0%, stomach at 32.0%, teeth at 29.5%, and weight at 29.0%. (Phillips et al.)

Among men preoccupied with body build, 90% thought they were too small or not muscular enough; BDD means persistent preoccupation, checking, comparison, and impairment—not wanting more muscle.

Caveat: these comparisons come from people who already had BDD, not all men who lift or care about appearance.

How common is muscle dysmorphia among men who lift?

There is no honest single percentage because muscle dysmorphia estimates change sharply with the ruler. The lowest-bias figure is 1.3% from a clinical interview; selected gym or military screens are much higher.

Muscle dysmorphia is a BDD specifier for believing one’s physique is too small. Introduced in 1997, it was assessed with eight tools across 31 studies, so “prevalence” may measure different things. (StatPearls; Mitchell et al.)

Most ordinary lifters are not disordered: comparison weightlifters showed little psychopathology in one case-control study. Concern rises when training, food, checking, or avoidance center on feeling too small. (Olivardia et al.)

Caveat: 49.8% is a screening result from a convenience sample, not diagnostic prevalence.

Why is BDD so common in cosmetic and dermatology clinics, and does cosmetic surgery help?

BDD is concentrated in places where people seek appearance change, but a procedure usually does not treat the disorder itself. The 2016 review estimated 13.2% in general cosmetic surgery, 20.1% in rhinoplasty, 11.2% in orthognathic surgery, and 11.3% among dermatology outpatients. Later reviews provide the table’s comparisons (Veale et al.; Salari et al.; Nabavizadeh et al.; Sáenz-Ravello et al.).

BDD is more common among people seeking these treatments, but the treatment rarely fixes it: among 42 surgical or minimally invasive treatments, severity improved after only 2.3%. (Crerand et al.)

That is “rarely,” not “never”: a critical review found mostly poor outcomes, though mild localized BDD may benefit. NICE recommends BDD-experienced mental-health assessment when BDD accompanies a cosmetic or dermatological request. (Bowyer et al.; NICE)

Caveat: clinic estimates vary widely; in one meta-analysis, individual study estimates ranged from 2.21% to 56.67%.

How often is body dysmorphia missed?

It is missed often enough that “nobody has diagnosed me” is weak evidence that nothing is wrong. In 500 psychiatric outpatients, routine interviews found none; structured interviews found 16, or 3.2%, in 500 comparable patients. (Zimmerman and Mattia)

Among 122 psychiatric inpatients, 16 had BDD, none had been diagnosed by their treating doctor, and all said shame would stop them raising it unless asked. In a German online sample meeting BDD criteria, only 15.2% had received a BDD diagnosis and 39.9% mental health treatment. (Grant et al.; Schulte et al.)

BDD commonly begins before adulthood; in 200 people, mean onset was 16.4 years and the most common onset age was 13. Shame can hide it. DSM-5-TR insight ranges from recognizing the belief is probably untrue to absent insight, where it is held as delusional. (Phillips et al.; StatPearls)

Caveat: these figures show a detection problem, not a population-wide rate.

How serious is it, and does it get better with treatment?

BDD can be serious, but it is treatable, and the evidence points toward BDD-specific care rather than endless appearance correction. A meta-analysis of 17 studies found higher suicidality; another of 23 studies estimated lifetime attempts at 35.2%, current ideation at 37.2%, and lifetime ideation at 66.1%. (Angelakis et al.; Pellegrini et al.)

These are mostly severe clinical samples, not a claim about everyone with BDD. Among 185 people followed up to 4 years, suicidal ideation occurred at 57.8% per year, attempts at 2.6% per year, and completed suicide at 0.3% per year, based on 2 people. If you are thinking about suicide, in the US call or text 988; elsewhere contact local emergency services. (Phillips and Menard; Phillips et al.; 988 Suicide & Crisis Lifeline)

Over 4 years, full remission was 0.20 and full or partial remission 0.55; 0.42 of remitters later fully relapsed. NICE recommends CBT for mild impairment, an SSRI or more intensive CBT for moderate impairment, and both for severe impairment. (Phillips et al.; NICE)

Evidence is concrete: a meta-analysis of 7 randomized controlled trials found CBT reduced symptoms more than waitlist or placebo, with gains maintained at 2–4 months; a placebo-controlled trial found 53% responded to fluoxetine versus 18% on placebo over 12 weeks. (Harrison et al.; Phillips et al.)

More checking can feel like control while making concern central. Our guide on how to quit looksmaxxing forums treats the exit as a mental-health issue.

Caveat: trials are small, follow-up is short, and relapse remains possible; improvement is realistic, not instant.

How to cite this page

Suggested citation: Real World Appeal. “Body dysmorphia statistics: how common BDD really is, what it looks like in men, and why it goes unasked.” realworldappeal.com, September 2026. https://realworldappeal.com/blog/body-dysmorphia-statistics

The primary sources are linked throughout so journalists, clinicians, students, and answer engines can cite the original studies directly. Sources were retrieved on 10 September 2026.

The bottom line

BDD is best described as not rare — unasked: about 1.9% of adults in pooled community estimates, with adult men and women broadly similar in national figures. Rates rise in cosmetic settings, while procedures rarely treat the distress engine.

Your appearance does not have a number that decides your life. Persistent checking, shame, and lost time are different. For ordinary photo curiosity, Real World Appeal offers a free read at /test; it is not clinical help if you feel stuck checking.

Sources

• Veale D, Gledhill LJ, Christodoulou P, Hodsoll J. (2016). Body dysmorphic disorder in different settings: A systematic review and estimated weighted prevalence. Body image 18:168–86. https://pubmed.ncbi.nlm.nih.gov/27498379/
• Koran LM, Abujaoude E, Large MD, Serpe RT. (2008). The prevalence of body dysmorphic disorder in the United States adult population. CNS spectrums 13(4):316–22. https://pubmed.ncbi.nlm.nih.gov/18408651/
• Rief W, Buhlmann U, Wilhelm S, Borkenhagen A, et al. (2006). The prevalence of body dysmorphic disorder: a population-based survey. Psychological medicine 36(6):877–85. https://pubmed.ncbi.nlm.nih.gov/16515733/
• Buhlmann U, Glaesmer H, Mewes R, Fama JM, et al. (2010). Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry research 178(1):171–5. https://pubmed.ncbi.nlm.nih.gov/20452057/
• Schieber K, Kollei I, de Zwaan M, Martin A. (2015). Classification of body dysmorphic disorder - what is the advantage of the new DSM-5 criteria? Journal of psychosomatic research 78(3):223–7. https://pubmed.ncbi.nlm.nih.gov/25595027/
• Rück C, Mataix-Cols D, Feusner JD, Shavitt RG, et al. (2024). Body dysmorphic disorder. Nature reviews. Disease primers 10(1):92. https://pubmed.ncbi.nlm.nih.gov/39639018/
• McGrath LR, Oey L, McDonald S, Berle D, et al. (2023). Prevalence of body dysmorphic disorder: A systematic review and meta-analysis. Body image 46:202–211. https://pubmed.ncbi.nlm.nih.gov/37352787/
• Enander J, Ivanov VZ, Mataix-Cols D, Kuja-Halkola R, et al. (2018). Prevalence and heritability of body dysmorphic symptoms in adolescents and young adults: a population-based nationwide twin study. Psychological medicine 48(16):2740–2747. https://pubmed.ncbi.nlm.nih.gov/29486813/
• Phillips KA, Menard W, Fay C, Weisberg R. (2005). Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 46(4):317–25. https://pmc.ncbi.nlm.nih.gov/articles/PMC1351257/
• Phillips KA, Menard W, Fay C. (2006). Gender similarities and differences in 200 individuals with body dysmorphic disorder. Comprehensive psychiatry 47(2):77–87. https://pmc.ncbi.nlm.nih.gov/articles/PMC1592235/
• Mitchell L, Murray SB, Cobley S, Hackett D, et al. (2017). Muscle dysmorphia symptomatology and associated psychological features in bodybuilders and non-bodybuilder resistance trainers: A systematic review and meta-analysis. Sports medicine 47(2):233–259. https://pubmed.ncbi.nlm.nih.gov/27245060/
• Rica R, Sepúlveda AR. (2024). Going deeper into eating and body image pathology in males: Prevalence of muscle dysmorphia and eating disorders in a university representative sample. European eating disorders review 32(2):363–377. https://pubmed.ncbi.nlm.nih.gov/37966996/
• Olivardia R, Pope HG, Hudson JI. (2000). Muscle dysmorphia in male weightlifters: a case-control study. The American journal of psychiatry 157(8):1291–6. https://pubmed.ncbi.nlm.nih.gov/10910793/
• Nicewicz HR, Torrico TJ, Boutrouille JF. (2024). Body Dysmorphic Disorder. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK555901/
• Salari N, Kazeminia M, Heydari M, Darvishi N, et al. (2022). Body dysmorphic disorder in individuals requesting cosmetic surgery: A systematic review and meta-analysis. Journal of plastic, reconstructive & aesthetic surgery 75(7):2325–2336. https://pubmed.ncbi.nlm.nih.gov/35715310/
• Nabavizadeh SS, Naseri R, Sadeghi E, Afshari A, et al. (2023). Prevalence of body dysmorphic disorder in rhinoplasty candidates: A systematic review and meta-analysis. Health science reports 6(8):e1495. https://pubmed.ncbi.nlm.nih.gov/37599660/
• Sáenz-Ravello G, Carrasco García P, Fan S, Al-Nawas B. (2025). Prevalence of Body Dysmorphic Disorder in Patients Seeking Orthognathic Surgery: A Systematic Review and Meta-Analysis. Journal of oral and maxillofacial surgery 83(11):1351–1362. https://pubmed.ncbi.nlm.nih.gov/40782826/
• Crerand CE, Menard W, Phillips KA. (2010). Surgical and minimally invasive cosmetic procedures among persons with body dysmorphic disorder. Annals of plastic surgery 65(1):11–6. https://pubmed.ncbi.nlm.nih.gov/20467296/
• Bowyer L, Krebs G, Mataix-Cols D, Veale D, et al. (2016). A critical review of cosmetic treatment outcomes in body dysmorphic disorder. Body image 19:1–8. https://pubmed.ncbi.nlm.nih.gov/27517118/
• Zimmerman M, Mattia JI. (1998). Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Comprehensive psychiatry 39(5):265–70. https://pubmed.ncbi.nlm.nih.gov/9777278/
• Grant JE, Kim SW, Crow SJ. (2001). Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. The Journal of clinical psychiatry 62(7):517–22. https://pubmed.ncbi.nlm.nih.gov/11488361/
• Schulte J, Schulz C, Wilhelm S, Buhlmann U. (2020). Treatment utilization and treatment barriers in individuals with body dysmorphic disorder. BMC psychiatry 20(1):69. https://pubmed.ncbi.nlm.nih.gov/32070300/
• Angelakis I, Gooding PA, Panagioti M. (2016). Suicidality in body dysmorphic disorder (BDD): A systematic review with meta-analysis. Clinical psychology review 49:55–66. https://pubmed.ncbi.nlm.nih.gov/27607741/
• Pellegrini L, Maietti E, Rucci P, Burato S, et al. (2021). Suicidality in patients with obsessive-compulsive and related disorders (OCRDs): A meta-analysis. Comprehensive psychiatry 108:152246. https://pubmed.ncbi.nlm.nih.gov/34062378/
• Phillips KA, Menard W. (2006). Suicidality in body dysmorphic disorder: a prospective study. The American journal of psychiatry 163(7):1280–2. https://pubmed.ncbi.nlm.nih.gov/16816236/
• Phillips KA, Coles ME, Menard W, Yen S, et al. (2005). Suicidal ideation and suicide attempts in body dysmorphic disorder. The Journal of clinical psychiatry 66(6):717–25. https://pubmed.ncbi.nlm.nih.gov/15960564/
• Phillips KA, Menard W, Quinn E, Didie ER, et al. (2013). A 4-year prospective observational follow-up study of course and predictors of course in body dysmorphic disorder. Psychological medicine 43(5):1109–17. https://pubmed.ncbi.nlm.nih.gov/23171833/
• Harrison A, Fernández de la Cruz L, Enander J, Radua J, et al. (2016). Cognitive-behavioral therapy for body dysmorphic disorder: A systematic review and meta-analysis of randomized controlled trials. Clinical psychology review 48:43–51. https://pubmed.ncbi.nlm.nih.gov/27393916/
• Phillips KA, Albertini RS, Rasmussen SA. (2002). A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Archives of general psychiatry 59(4):381–8. https://pubmed.ncbi.nlm.nih.gov/11926939/
• National Institute for Health and Care Excellence (NICE). (2005). Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) — Recommendations. https://www.nice.org.uk/guidance/cg31/chapter/1-Recommendations
• 988 Suicide & Crisis Lifeline. (2026). 988 Suicide & Crisis Lifeline. https://988lifeline.org/